Author

Sang Eun Lee

Seoul National UniversityPrimary ORCID profile (0000-0002-0799-4701 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Sang Eun LeeiD1 paper · The University of Texas at San Antonio Health Science Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Ae Jin Choi· 1 shared D G Jang· 1 shared Dohee KimiD· 1 shared Hae Rim JungiD· 1 shared Jae‐Joong KimiD· 1 shared Jaeik OhiD· 1 shared Seungjae ShiniD· 1 shared Soo-Jin LeeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ae Jin Choi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancers

Jae‐Joong Kim, Jaeik Oh, D G Jang, Seungjae Shin, Soo-Jin Lee, Sang Eun Lee, Yoojin Yang, Dohee Kim, Ae Jin Choi, Hae Rim Jung, Yumi Oh, Sung‐Yup Cho

This study identifies WRN as a therapeutic target in ARID1A-mutated cancers, showing that its inhibition causes DNA damage and cell death, with potential for combination therapy with p21 inhibition.

Science Advances · Jun 5, 2026Peer-reviewedCancer Biology